Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection

Acute Renal Failure Clinical Trial

— StV 11-2008  

Official title:

Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00743132
• Other study ID #: StV 11-2008
• Secondary ID: StV 11-2008
• Status: Completed
• Phase: N/A
• First received: August 27, 2008
• Last updated: January 22, 2010
• Start date: April 2008
• Est. completion date: December 2008

Study information

• Verified date: January 2010
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

Description:

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 569
• Est. completion date: December 2008
• Est. primary completion date: October 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient age >/= 18 years

• Benign and malign liver diseases

Exclusion Criteria:

• Trauma cases

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Acute Kidney Injury
• Acute Renal Failure
• Renal Insufficiency

Locations

Country	Name	City	State
Switzerland	Swiss HPB (Hepato-Pancreato-Biliary) Center of the University Hospital Zurich	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Predictor score			Yes
Primary	Incidence of ARF Length of hospital stay			Yes